10x Genomics SMA 50
¿Qué es el SMA 50 de 10x Genomics?
El SMA 50 de 10x Genomics, Inc. es $21 +6.19%
¿Cuál es la definición de SMA 50?
SMA 50 es un precio promedio de las acciones de los últimos 50 días calculado como una media no ponderada de los previos 50 precios de cierre de acciones.
Simple moving average of 50 days for a stock is an unweighted moving average over the past 50 days. Moving averages will always exhibit a lag and the longer the period used for averaging the greater the lag will be. Because of the large amounts of data considered when calculating a long-term moving average, it takes a considerable amount of movement in the market to cause the moving average to change its course.
Using a moving average to confirm a trend in price is one of the most basic, yet effecting ways of using the indicator. Moving averages take into account what has already happened and a whole range of past events, which makes them such a good technical analysis tool for trend confirmations. Generally, a long-term moving average that is clearly on the upswing is a confirmation of a bullish trend. Conversely, a long-term moving average that is clearly on the downswing is a confirmation of a bearish trend.
SMA 50 de compañías en Sector Health Care en NASDAQ en comparadas con 10x Genomics
¿Qué hace 10x Genomics?
10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in North America, Europe, the Middle East, Africa, China, and the Asia Pacific. The company provides chromium and chromium connect instruments, microfluidic chips, slides, reagents, and other consumables products. Its single cell solutions runs on its chromium instruments, which include single cell gene expression for measuring gene activity on a cell-by-cell basis; single cell immune profiling for measuring the activity of immune cells and their targets; single cell ATAC for measuring epigenetics comprising the physical organization of DNA; and single cell multiome ATAC + gene expression for measuring the genetic activity and epigenetic programming in the same cells across tens of thousands of cells in a single experiment. The company also provides visium spatial gene expression solution for measuring spatial gene expression patterns across a single tissue sample or gene expression and protein co-detection when combined with immunofluorescence. It serves various academic, government, biopharmaceutical, biotechnology, and other institutions. The company was formerly known as 10X Technologies, Inc. and changed its name to 10x Genomics, Inc. in November 2014. 10x Genomics, Inc. was incorporated in 2012 and is headquartered in Pleasanton, California.
Empresas con sma 50 similar a 10x Genomics
- PharmaSGP SE tiene SMA 50 de €21 -2.42%
- Opiant Pharmaceuticals Inc tiene SMA 50 de $21 -0.28%
- XD tiene SMA 50 de HKD$21 -14.07%
- Gencor Industries tiene SMA 50 de $21 -9.45%
- Recipe Unlimited tiene SMA 50 de CAD$21 +0.07%
- Hindusthan National Glass & Industries tiene SMA 50 de ₨21 +14.18%
- 10x Genomics tiene SMA 50 de $21 +6.19%
- First Bancorp PR tiene SMA 50 de $21 -5.06%
- Franklin Liberty U.S. Treasury Bond ETF tiene SMA 50 de $21 +2.18%
- Arena Events plc tiene SMA 50 de GBX21 +1.24%
- Virtus Diversified Income & Convertible Fund tiene SMA 50 de $21 +1.37%
- Wells Fargo tiene SMA 50 de $21 +3.42%
- TD Q U.S. Low Volatility ETF tiene SMA 50 de CAD$21 +2.73%